The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Psoriatic Disease Linked to Higher Risk of Uveitis & Vice Versa

Psoriatic Disease Linked to Higher Risk of Uveitis & Vice Versa

August 7, 2015 • By Rob Goodier

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Two classes of inflammatory diseases, uveitis and psoriatic disease, appear linked, as a diagnosis of one increases the risk of developing the other, new research has found.

You Might Also Like
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Psoriatic Arthritis Linked to Increased Heart Disease Risk
  • Psoriasis Tied to Higher Risk of Serious Liver Disease

A study of Danish patient registries found nearly triple the rate of uveitis among patients with psoriatic arthritis compared to the general population, and double among patients with severe psoriasis. Likewise, patients with uveitis had a four-fold higher rate of psoriatic arthritis and more than double the rate of severe psoriasis, according to research published online July 29 in JAMA Dermatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Fortunately, the absolute number of patients with psoriasis who develop uveitis, and vice versa, is low. However, increased focus on eye symptoms in patients with psoriasis and on skin and joint symptoms in patients with prior or current uveitis may be appropriate,” lead author Dr. Alexander Egeberg, of Gentofte Hospital at the University of Copenhagen, Denmark, told Reuters Health by email.

The evaluation included about 5.5 million patients over a 15-year period. Among them, Dr. Egeberg and colleagues found 74,129 cases of psoriasis and psoriatic arthritis and 13,114 cases of uveitis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers found that the patients with uveitis developed severe psoriasis at a rate of 2.66 per 10,000 person-years, compared to 1.12 in the general population. And they developed psoriatic arthritis at a rate of 4.25 per 10,000 person-years, versus 1.04 in the general population.

The link appeared in the other direction, too, as patients with psoriatic arthritis developed uveitis at a rate of 5.49 per 10,000 person-years, compared to 2.02 in the general population. And severe psoriasis patients developed uveitis at a rate of 4.23 per 10,000 person-years.

Poisson regression modeling calculated incidence ratios adjusted for age, sex, socioeconomic status, and comorbidities that included herpes, inflammatory bowel disease and sarcoidosis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

According to the model, uveitis patients have a higher risk of developing severe psoriasis at an adjusted incidence ratio of 2.17 (p<0.001) and of developing psoriatic arthritis at a ratio of 3.77 (p<0.001).

Patients with severe psoriasis have a higher risk of developing uveitis at an adjusted ratio of 1.40. And for patients with psoriatic arthritis, the researchers calculated a ratio of 2.50 (p<0.001).

The link between the inflammatory disorders may stem from the systemic nature of psoriatic disease, Dr. Egeberg said.

“Shared genetic susceptibility and systemic inflammation appear to play a significant role in the relationship between psoriasis and uveitis,” Dr. Egeberg said.

This research was supported by Pfizer, the LEO Foundation, and the Novo Nordisk Foundation. Dr. Egeberg is a Pfizer employee and one coauthor is employed by Eli Lilly and Company.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: comorbidities, Psoriatic Arthritis, Uveitis

You Might Also Like:
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Psoriatic Arthritis Linked to Increased Heart Disease Risk
  • Psoriasis Tied to Higher Risk of Serious Liver Disease
  • Treating IBD with Anti-TNF Tied to Higher Risk of Demyelinating Disease

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)